NCT06821750View on ClinicalTrials.gov

A Study to Learn How Different Amounts of the Study Medicine Called PF-07314470 Are Tolerated and Act in the Body in Healthy Adults

PHASE1TerminatedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

February 11, 2025

Primary Completion Date

August 18, 2025

Study Completion Date

August 18, 2025

Conditions
Healthy
Interventions
BIOLOGICAL

PF-07314470

subcutaneous injection

BIOLOGICAL

Placebo for PF-07314470

subcutaneous injection

Trial Locations (1)

06511

Pfizer Clinical Research Unit - New Haven, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY